Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy

Salih Subari, Firas Baidoun, Muhanad Hreh, Mrinal Patnaik, Shahrukh Hashmi, Michelle Elliott, William Hogan, Mark Litzow, Aref Al-Kali

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences